Latest news with #AfyaLimited
Yahoo
12 hours ago
- Business
- Yahoo
Afya Limited Announces Results of Annual General Meeting Held on June 24, 2025
NOVA LIMA, Brazil, June 24, 2025--(BUSINESS WIRE)--Afya Limited, or "Afya" (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 9, 2025 was duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2024; (2) the re-appointment of João Paulo Seibel de Faria as an independent director of the Company with immediate effect to hold office for a two year term; (3) the re-appointment of Vanessa Claro Lopes as an independent director of the Company with immediate effect to hold office for a two year term; (4) the re-appointment of Miguel Filisbino Pereira de Paula as an independent director of the Company with immediate effect to hold office for a two year term; and (5) the re-appointment of Marcelo Ken Suhara as an independent director of the Company with immediate effect to hold office for a two year term. About Afya Limited Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career. View source version on Contacts Investor Contact: ir@ IR Website:
Business Wire
12 hours ago
- Business
- Business Wire
Afya Limited Announces Results of Annual General Meeting Held on June 24, 2025
NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited, or 'Afya' (Nasdaq: AFYA) announced today that the resolutions set out in its Notice of Annual General Meeting dated June 9, 2025 was duly passed at its Annual General Meeting held today: (1) the approval and ratification of Afya's financial statements as of and for the fiscal year ended December 31, 2024; (2) the re-appointment of João Paulo Seibel de Faria as an independent director of the Company with immediate effect to hold office for a two year term; (3) the re-appointment of Vanessa Claro Lopes as an independent director of the Company with immediate effect to hold office for a two year term; (4) the re-appointment of Miguel Filisbino Pereira de Paula as an independent director of the Company with immediate effect to hold office for a two year term; and (5) the re-appointment of Marcelo Ken Suhara as an independent director of the Company with immediate effect to hold office for a two year term. About Afya Limited Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.
Yahoo
3 days ago
- Business
- Yahoo
The total return for Afya (NASDAQ:AFYA) investors has risen faster than earnings growth over the last three years
By buying an index fund, you can roughly match the market return with ease. But if you choose individual stocks with prowess, you can make superior returns. For example, the Afya Limited (NASDAQ:AFYA) share price is up 69% in the last three years, clearly besting the market return of around 49% (not including dividends). On the other hand, the returns haven't been quite so good recently, with shareholders up just 4.9%, including dividends. While this past week has detracted from the company's three-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Afya was able to grow its EPS at 42% per year over three years, sending the share price higher. The average annual share price increase of 19% is actually lower than the EPS growth. So it seems investors have become more cautious about the company, over time. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). It is of course excellent to see how Afya has grown profits over the years, but the future is more important for shareholders. This free interactive report on Afya's balance sheet strength is a great place to start, if you want to investigate the stock further. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Afya the TSR over the last 3 years was 71%, which is better than the share price return mentioned above. And there's no prize for guessing that the dividend payments largely explain the divergence! Afya provided a TSR of 4.9% over the last twelve months. But that return falls short of the market. But at least that's still a gain! Over five years the TSR has been a reduction of 4% per year, over five years. It could well be that the business is stabilizing. Before forming an opinion on Afya you might want to consider these 3 valuation metrics. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
02-06-2025
- Business
- Yahoo
Afya Limited Announces Change of Independent Registered Public Accounting Firm
NOVA LIMA, Brazil, June 02, 2025--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that its board of directors (the "Board"), following the recommendation of the Board's audit committee, recently approved the engagement of KPMG Auditores Independentes Ltda. ("KPMG") to provide independent auditing services for the Company, replacing Ernst & Young Auditores Independentes S/S Ltda., as its independent registered public accounting firm. KPMG will commence its activities with the review of our quarterly information for the second quarter of 2025. About Afya Limited (Nasdaq: AFYA, B3: A2FY34) Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career. View source version on Contacts Investor Relations Contact:Afya Limitedir@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Business Wire
02-06-2025
- Business
- Business Wire
Afya Limited Announces Change of Independent Registered Public Accounting Firm
NOVA LIMA, Brazil--(BUSINESS WIRE)-- Afya Limited (Nasdaq: AFYA; B3: A2FY34) ('Afya' or the 'Company '), the leading medical education group and medical practice solutions provider in Brazil, announced today that its board of directors (the 'Board'), following the recommendation of the Board's audit committee, recently approved the engagement of KPMG Auditores Independentes Ltda. ('KPMG') to provide independent auditing services for the Company, replacing Ernst & Young Auditores Independentes S/S Ltda., as its independent registered public accounting firm. KPMG will commence its activities with the review of our quarterly information for the second quarter of 2025. About Afya Limited (Nasdaq: AFYA, B3: A2FY34) Afya is a leading medical education group in Brazil based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career.
